Investor Overview

Our Investor Information

Company Overview

Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care for patients living with rare genetic diseases of obesity.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Annual Report
Press Releases
July 27, 2021
Rhythm Pharmaceuticals to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
July 23, 2021
Rhythm Pharmaceuticals Announces European Commission Authorization of IMCIVREE® (setmelanotide)▼ for the Treatment of Obesity and Control of Hunger Associated with POMC, PCSK1 and LEPR Deficiency
Upcoming Events
August 3, 2021 at 8:00 AM EDT
Rhythm Pharmaceuticals Q2 2021 Earnings Conference Call
Investor FAQs
More FAQs are coming soon.


Delaware, November 2008


222 Berkeley Street, 12th Floor
Boston, MA 02116

CUSIP number


Transfer Agent

Computershare Trust Company, Inc.
250 Royall Street
Canton, MA 02021
US Phone: +1-800-962-4284
International Phone: + 1-781-575-3120